TH1902 in Patients With Advanced Solid Tumors
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Solid Tumor|TNBC - Triple-Negative Breast Cancer|Hormone Receptor-positive Breast Cancer|Epithelial Ovarian Cancer|Endometrial Cancer|Cutaneous Melanoma|Thyroid Cancer|Small-cell Lung Cancer|Prostate Cancer|SORT1+ Cancers
Interventions: DRUG: TH1902
Sponsor: Theratechnologies
Collaborators: PPD|Altasciences Company Inc.|Windtree Therapeutics|Syneos Health|Innovaderm Research Inc.